Results for tag: "Epclusa"

Epclusa is a prescription medication used to treat chronic hepatitis C virus (HCV) infection. It is a combination of two antiviral drugs, sofosbuvir and velpatasvir, and is used to treat all six major genotypes of HCV. Epclusa is the first single-tablet regimen approved by the US Food and Drug Administration (FDA) for the treatment of HCV infection. It is also approved for use in the European Union and other countries. Epclusa is part of a growing market of infectious diseases drugs, which includes other antiviral medications, antibiotics, and vaccines. These drugs are used to treat a variety of bacterial and viral infections, including HIV, influenza, and malaria. The market for infectious diseases drugs is expected to continue to grow as new treatments are developed and existing treatments are improved. Some of the companies in the Epclusa market include Gilead Sciences, Merck, and AbbVie. Show Less Read more